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ABSTRACT 
IgA nephropathy (IgAN) is the most common form of primary GN and an important cause of kidney failure. 
Characteristically, patients with IgAN have increased serum levels of undergalactosylated IgA1 (gd-IgA1). 
To assess the degree to which serum gd-IgA1 levels are genetically determined in healthy individuals, we 
determined serum IgA and gd-IgA1 levels by ELISA in a sample of 148 healthy female twins, including 27 
monozygotic and 47 dizygotic pairs. Using the classical twin model, we found the heritability of serum gd-
IgA1 and IgA levels to be 80% (95% confidence interval: 66% to 89%) and 46% (95% confidence interval: 
15% to 69%), respectively. These data indicate that serum gd-IgA1 levels are highly heritable. Elucidating 
the genetic basis of this heritability will be important in understanding the pathogenesis of IgAN.  
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MAIN TEXT 
IgA Nephropathy (IgAN) is the most frequently diagnosed type of glomerulonephritis in the world.
1
 The 
course of disease is complex and not yet fully understood. Prognosis is variable. Some patients have a very 
mild form of the disease that requires little to no treatment. However, others have progressive disease with 
up to 50% of patients developing end stage renal failure within 20 years of diagnosis. IgAN recurs in 
approximately 50-60% of transplanted patients, indicating an important contribution of extra-renal factors 
to pathogenesis.
2,3,4,5
 A great deal of evidence exists to support a significant genetic contribution to 
IgAN.
5,6,7,8,9
 The incidence of IgAN varies geographically, being most prevalent in East Asian populations and 
less prevalent in European and African populations.
10,11
 Six genome wide association studies (GWAS) have 
collectively identified 20 distinct loci associated with IgAN. Interestingly, most of these loci are shared with 
other immune-related diseases.
12,13,14,15,16,17
 One associated SNP has been located within the ST6GAL1 gene.
16
 
ST6GAL1 encodes ST6 beta-galactosamide alpha-2,6-sialyltranferase 1, a glycosyltransferase. However, none 
of the loci are specifically associated with genes involved in IgA1 glycosylation. One of the hallmarks of IgAN 
is the presence of increased amounts of circulating under-galactosylated IgA1 antibodies. Usually, glycans on 
the hinge region of IgA1 terminate with galactose. In IgAN patients an increased proportion of IgA1 glycans 
terminate in N-acetylgalactosamine (GalNAc) or sialylated GalNAc.
5,18
 This type of IgA1 is termed ‘galactose-
deficient’ IgA1 (gd-IgA1). Galactose-deficient IgA1 has an established role in the development of IgAN. In the 
proposed 4-hit hypothesis of IgAN pathogenesis, an increase in gd-IgA1 triggers the production of anti-glycan 
auto-antibodies.
8,19,20
 This leads to the formation of immune complexes that, under this hypothesis, may 
deposit in the kidney and cause kidney injury.
21,22
 Levels of gd-IgA1 are elevated in IgAN patients, regardless 
of ethnicity or age.
23,24,45 
Studies of familial IgAN have provided heritability estimates for gd-IgA1 between 54% and 76%.
25,26,27
 One 
difficulty of these studies is that at-risk relatives tend to show increased gd-IgA1 levels, biasing the 
heritability estimates, which have been suggested to strongly depend on the gd-IgA1 levels of the index IgAN 
case.
26
 In order to understand the genetic contribution to gd-IgA1 levels in IgAN patients, it is first necessary 
to understand the genetic contribution to gd-IgA1 levels in healthy individuals. The classical twin model 
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allows the estimation of the environmental and genetic contribution to phenotypic variation. We assessed 
the heritability of serum gd-IgA1 and IgA levels in a randomly ascertained sample of 148 healthy female 
twins from the TwinsUK cohort consisting of 47 dizygotic and 27 monozygotic pairs. All individuals were 
female of white Caucasian ethnicity. The mean age was 56.9 years (range=27.1-84.8, SD=13). Phenotypic 
characteristics are summarised in Table 1.  
 
We measured IgA and gd-IgA1 levels in serum by ELISA. To demonstrate consistency among multiple 
measurements of both IgA and gd-IgA1, we designed a fully-crossed experiment, where 58 randomly 
selected control samples were assessed on three testing days. We assessed the intra-rater reliability of each 
experiment by calculating the intra-class correlation coefficient (ICC).
28
 The ICC for the IgA assay was 0.74 
(95% CI: 0.63-0.83) and the ICC for the gd-IgA1 assay was 0.89 (95% CI: 0.73-0.95), showing a good to 
excellent reproducibility.
29
 We next assessed serum IgA and gd-IgA1 levels in our Twin cohort. The mean 
serum IgA level was 3.16 mg/ml (range 0.91 to 5.41, SD=0.73). The mean serum gd-IgA1 level was 0.54 AU 
(range 0.21 to 0.89, SD=0.15). For both parameters the data were normally distributed (P>0.05, Shapiro-Wilk 
normality test). To control for potential batch effects analyses were carried out using the plate-adjusted 
residuals for both traits and age at assessment was included in all models. To determine longitudinal stability 
of gd-IgA1, we analysed gd-IgA1 levels in two samples from each individual (n=40 individuals). The samples 
were collected 5 years apart. There was no difference in HAA binding of the paired samples over time (Figure 
1, r=0.92, p<0.0001). This data demonstrated longitudinal stability of gd-IgA1 in the twins and is consistent 
with previous studies (reviewed in 
30
). 
 
We fitted three different nested genetic models to the data using OpenMX: a) the E model, which assumes 
that the phenotypic variability in the population is determined only by the Environment; b) the AE model 
which assumes that both Additive genetic effects and the Environment play a role; c) the ACE model that 
includes an additional component for the Common shared familial environment. The AE model was the best-
fitting model for the estimation of both gd-IgA1 and IgA level heritability (AICACE=-485.6; AICAE=-487.5 and 
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AICACE=11.0; AICAE=9.0, respectively). Additive genetic effects accounted for 80.4% (95% CI: 65.6-88.7%) of 
the variance of gd-IgA1 levels and individual-specific environment effects explained the remaining 19.6% 
(95% CI: 11.3-34.4%) of the variance. Additive genetic effects accounted for 46.3% (95% CI: 15.2-68.6%) of 
the variance of IgA levels, and individual-specific environment effects explained the remaining 53.7% (95% 
CI: 31.4-84.8%) of the variance. These data show that, unlike serum IgA, serum gd-IgA1 is highly heritable. 
This is confirmed by the fact that, in contrast to serum IgA levels, the correlation of gd-IgA1 between 
monozygotic twins (r=0.84) was much higher than the correlation between dizygous twins (r=0.46; Figure 2). 
Our analyses suggest that the variability of gd-IgA1 levels in the general healthy population is strongly 
determined by genes with additive effect on the trait, while the individual environment (lifestyle, exposure) 
plays a much smaller role. Analogously, no effects due to common environmental or lifestyle factors that are 
shared within each family were identified in our sample. Overall, our data show that circulating gd-IgA1 is 
highly heritable (80.4%) in a healthy population, indicating that serum gd-IgA1 levels are under strong 
genetic control. Heritability of gd-IgA1 has previously been demonstrated in studies based on families 
ascertained through the presence of IgA nephropathy or Henoch-Schonlein Purpura, though estimates were 
sometimes dependent on the gd-IgA1 levels of the index case.
25,26,27
 An increased level of gd-IgA1 is 
associated with IgAN and is considered to be the ‘first hit’ in the proposed disease pathogenesis model.
8,20
 
Notably, asymptomatic first-degree relatives of IgAN patients have high gd-IgA1 levels, suggesting that 
additional factors (‘hits’) are required for IgAN to develop. Consistent with previous studies, serum IgA levels 
showed low heritability (46.3%) in our cohort. 
31,32  
In conclusion, our study found gd-IgA1 levels to be a 
highly heritable trait in the general population, with a heritability estimate of about 80%. Disentangling the 
genetic component underlying gd-IgA1 variability may help the identification of genetic risk factors for IgAN 
susceptibility.  
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CONCISE METHODS 
Sample Cohort 
The TwinsUK adult twin registry includes about 12,000 subjects, predominately white Caucasian females 
unselected for any specific disease, and recruited from all over the UK from 1992. Individuals from the 
TwinsUK cohort have been shown to have similar disease and lifestyle characteristics to the general 
population.
33
 St. Thomas’ Hospital Research Ethics Committee approved the study, and all twins provided 
informed written consent. The sample used for this study was randomly ascertained among healthy twin 
pairs. All the data is available upon request from the Twin Research Unit website (www.twinsuk.ac.uk/data-
access/submission-procedure/).  
 
Measurement of Serum IgA 
Serum IgA levels were measured by ELISA.
23 
MaxiSorb immunoplates (Nunc; Life Technologies) were coated 
overnight at 4°C with 3 µg/ml F(ab’)2 fragment goat anti-human IgA (Jackson) in coating buffer (0.05 M 
Na2CO3 pH 9.6). In between each incubation step, plates were washed 3 times with washing buffer (PBST; 
0.1% Tween 20). Plates were blocked for 1 hour at room temperature with carbofree (Vector Labs). Samples 
were diluted 1/80,000 in carbofree and incubated at room temperature for 2 hours. Detection was carried 
out for 1 hour at room temperature using F(ab’)2 fragment biotinylated goat anti-human IgA1 (Jackson 
Immunoresearch), followed by Extravidin-HRP. ELISAs were developed using TMB substrate (BD Biosciences) 
and absorbance was measured at 450 nm. A standard curve was produced on each plate using serial 
dilutions of purified IgA1 (Abcam) from 100 ng/ml – 1.56 ng/ml. 
 
Measurement of gd-IgA1 
Levels of serum gd-IgA1 were measured using a lectin-based ELISA.
34
 MaxiSorb immunoplates were coated 
overnight at 4°C with polyclonal rabbit anti-human IgA (Dako) diluted 1/1000 in coating buffer (0.05 M 
Na2CO3 pH 9.6). In between each incubation step, plates were washed 4 times with washing buffer (PBST; 
0.1% Tween 20, 0.355 M NaCl). Plates were blocked for 1 hour at room temperature with carbofree (Vector 
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Labs) and samples were diluted 1/100 in PBS (to ensure saturation of IgA) and incubated overnight at 4°C. 
HAA-biotin (Sigma) diluted 1/1000 in PBS was added to each well for 90 min at room temperature, followed 
by poly-streptavidin HRP (Pierce) diluted 1/10,000 also for 90 min at room temperature. ELISAs were 
developed using TMB substrate (BD Biosciences) and absorbance was measured at 450 nm. Three control 
samples were run on each plate (“low”, “medium” and “high”), to test for inter- and intra- assay variation. 
 
Heritability Estimation 
We used openMX (http://openmx.psyc.virginia.edu/; version 2.2.4) to estimate the contribution of additive 
genetic (A), shared (C) and individual-specific environment (E) effects on serum IgA and gd-IgA1 level 
variation (ACE model).
35
 We also compared the ACE model with the most parsimonious AE model, which 
does not include the effect of common environment influences, assuming that all familial aggregation results 
from additive genetic effects, and against the E model that assumes all variability to be determined by the 
environment. The models were compared through Akaike's information criterion (AIC) in order to determine 
which model attained the best goodness-of-fit in the most parsimonious way. In the analyses the age at 
serum level collection was included as covariate.  
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FIGURE LEGENDS 
 
Figure 1. Stability of gd-IgA1 levels over time. Unpaired (A, bars represent group median) and paired (B) 
scatter plots show gd-IgA1 levels determined at 2 time points, T1 and T2 (5 years apart), for individual 
samples (n=40 individuals with paired samples from each). There was no difference in gd-IgA1 levels in the 
paired samples over time (paired t-test, P=NS), with a good correlation between T1 and T2 (C, r=0.92, 
P<0.0001, Pearson’s correlation).  
Figure 2. Twin by twin scatterplots. Serum gd-IgA1 levels in monozygotic (MZ; A) and dizygotic (DZ; B) twins 
and of serum IgA levels in MZ (C) and DZ (D) twins. The levels of gd-IgA1 were more correlated in MZ twins 
than in DZ twins; Intrapair correlations were 0.84 (P <0.0001) and 0.46 (P=0.001) respectively. These data 
suggest gd-IgA1 level is highly heritable. Conversely, intrapair correlations of IgA level were 0.48 (P = 0.01) 
and 0.30 (P=0.041) indicative of IgA level being less heritable than gd-IgA1 level. 
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Table 1. Phenotypic details of the 148 female Caucasian individuals in the study sample.  
 
  Mean  Standard 
deviation 
1
st
 quantile  3
rd
 quantile 
 
Monozygotic  N=54     
   Age   (years) 52.73 12.16 45.14 62.86 
   IgA  (mg/ml) 3.22 0.65 2.81 3.54 
   gd-IgA1 (AU) 0.54 0.16 0.42 0.66 
 
 
Dizygotic  
 
N=94 
    
   Age   (years) 59.28 12.98 48.91 69.76 
   IgA  (mg/ml) 3.13 0.77 2.62 3.67 
   gd-IgA1 (AU) 0.53 0.15 0.43 0.63 
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